Cargando…
Authors’ reply to the letter to editor “Acid suppressant use in association with incidence and severe outcomes of COVID‑19: a systematic review and meta‑analysis”
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108142/ https://www.ncbi.nlm.nih.gov/pubmed/35575913 http://dx.doi.org/10.1007/s00228-022-03334-x |
| _version_ | 1784708634472611840 |
|---|---|
| author | Kim, Hong-Bae Kim, Jung-Ha Wolf, Bethany J. |
| author_facet | Kim, Hong-Bae Kim, Jung-Ha Wolf, Bethany J. |
| author_sort | Kim, Hong-Bae |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9108142 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91081422022-05-16 Authors’ reply to the letter to editor “Acid suppressant use in association with incidence and severe outcomes of COVID‑19: a systematic review and meta‑analysis” Kim, Hong-Bae Kim, Jung-Ha Wolf, Bethany J. Eur J Clin Pharmacol Letter to the Editor Springer Berlin Heidelberg 2022-05-16 2022 /pmc/articles/PMC9108142/ /pubmed/35575913 http://dx.doi.org/10.1007/s00228-022-03334-x Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Kim, Hong-Bae Kim, Jung-Ha Wolf, Bethany J. Authors’ reply to the letter to editor “Acid suppressant use in association with incidence and severe outcomes of COVID‑19: a systematic review and meta‑analysis” |
| title | Authors’ reply to the letter to editor “Acid suppressant use in association with incidence and severe outcomes of COVID‑19: a systematic review and meta‑analysis” |
| title_full | Authors’ reply to the letter to editor “Acid suppressant use in association with incidence and severe outcomes of COVID‑19: a systematic review and meta‑analysis” |
| title_fullStr | Authors’ reply to the letter to editor “Acid suppressant use in association with incidence and severe outcomes of COVID‑19: a systematic review and meta‑analysis” |
| title_full_unstemmed | Authors’ reply to the letter to editor “Acid suppressant use in association with incidence and severe outcomes of COVID‑19: a systematic review and meta‑analysis” |
| title_short | Authors’ reply to the letter to editor “Acid suppressant use in association with incidence and severe outcomes of COVID‑19: a systematic review and meta‑analysis” |
| title_sort | authors’ reply to the letter to editor “acid suppressant use in association with incidence and severe outcomes of covid‑19: a systematic review and meta‑analysis” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108142/ https://www.ncbi.nlm.nih.gov/pubmed/35575913 http://dx.doi.org/10.1007/s00228-022-03334-x |
| work_keys_str_mv | AT kimhongbae authorsreplytothelettertoeditoracidsuppressantuseinassociationwithincidenceandsevereoutcomesofcovid19asystematicreviewandmetaanalysis AT kimjungha authorsreplytothelettertoeditoracidsuppressantuseinassociationwithincidenceandsevereoutcomesofcovid19asystematicreviewandmetaanalysis AT wolfbethanyj authorsreplytothelettertoeditoracidsuppressantuseinassociationwithincidenceandsevereoutcomesofcovid19asystematicreviewandmetaanalysis |